Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Canopy Growth: Neuer Online-Store, aber bekannte Zahlenschwäche...
Canopy Growth: Neuer Online-Store, aber bekannte Zahlenschwäche...

Canopy Growth (WKN: A140QA) goes online: Mit dem neuen Online-Store ShopCanopy versucht das Unternehmen aus Smith Falls, Kanada, seine E-Commerce-Aktivitäten zu intensivieren.

Doch bei einem

Relay & Fio Corp. Address Market Development and Fionet COVID-19 Applications
Relay & Fio Corp. Address Market Development and Fionet COVID-19 Applications

 

 

-          Government, Media, and Doctors Are Aligning on Need for Routine, Controlled Testing at Airports, Workplaces, Homes, and Other Decentralized Locations

-          Health Canada

Relay & Fio Corp. prüfen Marktentwicklung und COVID-19-Anwendungen für Fionet
Relay & Fio Corp. prüfen Marktentwicklung und COVID-19-Anwendungen für Fionet

 

 

-          Regierung, Medien und Ärzte stimmen sich über die Notwendigkeit von routinemäßigen, kontrollierten Tests an Flughäfen, Arbeitsplätzen, zu Hause und an anderen dezentralen Orten

Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today

Relay Medical and Fio Corporation Announce Signing Distribution Partners in U.S. & France for the Fionet Mobile COVID-19 Testing and Tracking Platform
Relay Medical and Fio Corporation Announce Signing Distribution Partners in U.S. & France for the Fionet Mobile COVID-19 Testing and Tracking Platform

-          Relay and Fio announce distribution partners in U.S. and France to market Fionet to pharmacies and certain other sectors

-          With 10x more locations than hospitals,

Relay Medical und Fio Corporation unterzeichnen Abkommen mit Vertriebspartnern in den USA und Frankreich für mobile COVID-19-Testungs- und Trackingplattform Fionet
Relay Medical und Fio Corporation unterzeichnen Abkommen mit Vertriebspartnern in den USA und Frankreich für mobile COVID-19-Testungs- und Trackingplattform Fionet

 

-          Relay und Fio kooperieren mit Vertriebspartnern in den USA und Frankreich, um Fionet über Apotheken und bestimmte andere Bereiche zu vermarkten.

-          Es gibt zehnmal mehr

Antibe Therapeutics to Present at Upcoming Conferences
Antibe Therapeutics to Present at Upcoming Conferences


Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF) today announced that the Company will be presenting at two conferences:



LD Micro 500 – Virtual Event
September 1, 2020 - 12:20pm (Eastern Time)

NeutriSci Provides Corporate Update on Contract Partner, New Markets and Product Line
NeutriSci Provides Corporate Update on Contract Partner, New Markets and Product Line

VANCOUVER, BC / ACCESSWIRE / August 31, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developi

NeutriSci mit Unternehmens-Update über Vertragspartner, neue Märkte und Produktlinien
NeutriSci mit Unternehmens-Update über Vertragspartner, neue Märkte und Produktlinien

VANCOUVER, BC / 31. August 2020 / NeutriSci International Inc. („NeutriSci“ oder das „Unternehmen“) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) - ein innovatives Technologieunternehmen, das

Relay Medical and Fio Corporation Launch Mobile COVID-19 Testing and Tracking Platform
Relay Medical and Fio Corporation Launch Mobile COVID-19 Testing and Tracking Platform

 

-          Fionet is a first-of-its-kind mobile testing platform for organizations to manage and track on-site COVID-19 testing

-          Fionet Devices, usable by non-expert personnel,

Relay Medical und Fio Corporation lancieren mobile COVID-19-Test- und Trackingplattform
Relay Medical und Fio Corporation lancieren mobile COVID-19-Test- und Trackingplattform

 

-          Fionet ist die allererste mobile Testplattform, die es Organisationen ermöglicht, COVID-19-Tests vor Ort zu verwalten und nachzuverfolgen.

-          Mit Fionet-Geräten, die

EnWave Signs Technology Evaluation and License Option Agreement with Leading European Snack Company
EnWave Signs Technology Evaluation and License Option Agreement with Leading European Snack Company

Vancouver, B.C., August 26th, 2020 - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company” - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) announced

EnWave unterzeichnet Technologieevaluierungs- und Lizenzoptionsvertrag mit führendem europäischen Snack-Unternehmen
IMV to Participate at Four Upcoming Investor Conferences
IMV to Participate at Four Upcoming Investor Conferences


IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious

EnWave Corporation Verfeinerungsentwicklung eines medizinischen Geräts zur Linderung der COVID-19-Symptome
EnWave Corporation Verfeinerungsentwicklung eines medizinischen Geräts zur Linderung der COVID-19-Symptome

 

Vancouver, B.C., 25. August 2020, Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) gab

EnWave Corporation Refining Development of a Medical Device to Relieve COVID-19 Symptoms
EnWave Corporation Refining Development of a Medical Device to Relieve COVID-19 Symptoms

 

Vancouver, B.C., August 25, 2020, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ), announced

Antibe Therapeutics Reports Q1 2021 Interim Financial and Operating Results
Antibe Therapeutics Reports Q1 2021 Interim Financial and Operating Results


Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF) filed its financial and operating results on Monday, August 24 for the fiscal quarter ended June 30, 2020. The

Antibe Therapeutics Announces Results of Annual and Special Meeting
Antibe Therapeutics Announces Results of Annual and Special Meeting


Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF) is pleased to announce the results of its annual and special meeting held earlier today. All resolutions outlined in the management information

EnWave berichtet das dritte Quartal des Geschäftsjahres 2020 am 27. August 2020 und gibt  Update zu NutraDried
EnWave berichtet das dritte Quartal des Geschäftsjahres 2020 am 27. August 2020 und gibt Update zu NutraDried

Vancouver, B.C., 20. August 2020 - Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ), ein

EnWave to Report Third Quarter Fiscal 2020 Financial Results on August 27, 2020 and Provides NutraDried Update
EnWave to Report Third Quarter Fiscal 2020 Financial Results on August 27, 2020 and Provides NutraDried Update

Vancouver, B.C., August 20th, 2020 - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ), a global

Relay Medical and Fio Corporation Announce Joint Venture for Pandemic Testing Technology
Relay Medical and Fio Corporation Announce Joint Venture for Pandemic Testing Technology

August 19, 2020 – Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), and Fio Corporation (“Fio”) are pleased to announce the establishment of a joint

Relay Medical und Fio Corporation gründen Joint Venture für Pandemie-Testmethode
Relay Medical und Fio Corporation gründen Joint Venture für Pandemie-Testmethode

19. August 2018 – Relay Medical Corp. („Relay“ oder das „Unternehmen“) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) und Fio Corporation („Fio“) freuen sich, die Gründung eines Joint Ventures („J

Relay Medical and Fio Corporation Extend MOU Agreement for Collaboration on a Rapid Diagnostic Testing Platform
Relay Medical and Fio Corporation Extend MOU Agreement for Collaboration on a Rapid Diagnostic Testing Platform

 

August 16, 2020 – Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), and Fio Corporation (“Fio”) jointly report that the Companies have extended the me

Relay Medical und Fio Corporation verlängern ihre Absichtserklärung bezüglich der Zusammenarbeit im Hinblick auf eine Schnelltest-Diagnoseplattform
Relay Medical und Fio Corporation verlängern ihre Absichtserklärung bezüglich der Zusammenarbeit im Hinblick auf eine Schnelltest-Diagnoseplattform

 

16. August 2020 – Relay Medical Corp. („Relay“ oder das „Unternehmen“) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) und Fio Corporation („Fio) berichten gemeinsam, dass die Unternehmen ihre am

IMV Inc. Announces Second Quarter 2020 Financial Results
IMV Inc. Announces Second Quarter 2020 Financial Results


IMV Inc. (the “Company” or “IMV”) (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases